tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

FR:IVA Stock Latest News

Inventiva: Strong Balance Sheet and Late-Stage MASH Candidate Lanifibranor Drive Compelling Buy Rating
RatingsInventiva: Strong Balance Sheet and Late-Stage MASH Candidate Lanifibranor Drive Compelling Buy Rating
5d ago
IVA
Inventiva initiated with an Overweight at Barclays
PremiumThe Fly
Inventiva initiated with an Overweight at Barclays
27d ago
IVA
Inventiva initiated with an Outperform at Leerink
PremiumThe Fly
Inventiva initiated with an Outperform at Leerink
1M ago
IVA
Inventiva upgraded to Buy from Neutral at UBS
PremiumThe Fly
Inventiva upgraded to Buy from Neutral at UBS
2M ago
IVA
Aligos Therapeutics initiated with a Buy at UBS
PremiumThe Fly
Aligos Therapeutics initiated with a Buy at UBS
2M ago
IVA
KOD
Positive Buy Rating for Inventiva Driven by Promising Phase 3 Trial and Strong Financial Position
PremiumRatingsPositive Buy Rating for Inventiva Driven by Promising Phase 3 Trial and Strong Financial Position
3M ago
IVA
Inventiva price target lowered to $11 from $13 at Guggenheim
Premium
The Fly
Inventiva price target lowered to $11 from $13 at Guggenheim
3M ago
IVA
Inventiva 32.47M share Spot Secondary priced at $3.85
Premium
The Fly
Inventiva 32.47M share Spot Secondary priced at $3.85
3M ago
IVA
Inventiva announves $125M American Depositary shares offering
PremiumThe Fly
Inventiva announves $125M American Depositary shares offering
3M ago
IVA
Wolfe starts Inventiva at Outperform on ‘constructive’ lanifibranor view
PremiumThe Fly
Wolfe starts Inventiva at Outperform on ‘constructive’ lanifibranor view
4M ago
IVA
Inventiva initiated with an Outperform at Wolfe Research
PremiumThe Fly
Inventiva initiated with an Outperform at Wolfe Research
4M ago
IVA
Inventiva S.A. trading resumes
PremiumThe Fly
Inventiva S.A. trading resumes
4M ago
IVA
Inventiva S.A. trading halted, volatility trading pause
PremiumThe FlyInventiva S.A. trading halted, volatility trading pause
4M ago
IVA
Inventiva files $300M mixed securities shelf
Premium
The Fly
Inventiva files $300M mixed securities shelf
4M ago
IVA
Buy Rating for Inventiva: Lanifibranor’s Potential as a Foundational MASH Therapy
Premium
Ratings
Buy Rating for Inventiva: Lanifibranor’s Potential as a Foundational MASH Therapy
5M ago
IVA
Inventiva price target raised to $24 from $20 at H.C. Wainwright
PremiumThe Fly
Inventiva price target raised to $24 from $20 at H.C. Wainwright
5M ago
IVA
Inventiva’s Strategic Focus and Financial Stability Drive Buy Rating Amid Promising Phase 3 Trial Progress
PremiumRatings
Inventiva’s Strategic Focus and Financial Stability Drive Buy Rating Amid Promising Phase 3 Trial Progress
5M ago
IVA
Inventiva management to meet with Piper Sandler
PremiumThe Fly
Inventiva management to meet with Piper Sandler
5M ago
IVA
Inventiva positioned as next acquisition target, says H.C. Wainwright
PremiumThe Fly
Inventiva positioned as next acquisition target, says H.C. Wainwright
5M ago
IVA
Buy Rating for Inventiva: Lanifibranor’s Promising Role in Metabolic Disease Treatment
PremiumRatingsBuy Rating for Inventiva: Lanifibranor’s Promising Role in Metabolic Disease Treatment
5M ago
IVA
Inventiva assumed with a Buy at H.C. Wainwright
Premium
The Fly
Inventiva assumed with a Buy at H.C. Wainwright
6M ago
IVA
Inventiva price target raised to $13 from $9 at Guggenheim
Premium
The Fly
Inventiva price target raised to $13 from $9 at Guggenheim
6M ago
IVA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >